Literature DB >> 10606893

Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes.

G Matteo Rigolin1, J Howard, A Buggins, C Sneddon, G Castoldi, W J Hirst, G J Mufti.   

Abstract

We have compared the phenotypic and functional characteristics of dendritic cells (DC) generated in vitro from the peripheral blood mononuclear fraction of myelodysplastic syndrome (MDS) patients (four refractory anaemia, four refractory anaemia with excess of blasts) with DCs generated in a similar way from eight healthy donors. After 10 d of culture in the presence of GM-CSF and IL-4, reduced numbers and percentages of DCs were obtained in MDS subjects. MDS DCs exhibited significantly lower expression of CD1a, CD54, CD80 and MHC class II molecules. Their ability to stimulate T lymphocytes in an allogeneic mixed leucocyte reaction was reduced in comparison to normal subjects. Furthermore, MDS DCs also showed a reduced receptor-mediated endocytosis as demonstrated by FITC-dextran uptake. Simultaneous fluorescence in situ hybridization (FISH) and immunophenotypic analysis demonstrated that MDS DCs have the same cytogenetic abnormality of the malignant clone. Taken together these findings indicate that, in MDS, DCs are part of the malignant clone and exhibit a deficient antigen uptake and presentation.

Entities:  

Mesh:

Year:  1999        PMID: 10606893     DOI: 10.1046/j.1365-2141.1999.01781.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Phenotypic and functional characteristics of dendritic cells derived from human peripheral blood monocytes.

Authors:  Ling-ling Tang; Zhe Zhang; Jie-sheng Zheng; Ji-fang Sheng; Ke-zhou Liu
Journal:  J Zhejiang Univ Sci B       Date:  2005-12       Impact factor: 3.066

2.  NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome.

Authors:  Elizabeth A Griffiths; Pragya Srivastava; Junko Matsuzaki; Zachary Brumberger; Eunice S Wang; Justin Kocent; Austin Miller; Gregory W Roloff; Hong Yuen Wong; Benjamin E Paluch; Linda G Lutgen-Dunckley; Brandon L Martens; Kunle Odunsi; Adam R Karpf; Christopher S Hourigan; Michael J Nemeth
Journal:  Clin Cancer Res       Date:  2017-09-25       Impact factor: 13.801

Review 3.  Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?

Authors:  Lisa Pleyer; Peter Valent; Richard Greil
Journal:  Int J Mol Sci       Date:  2016-06-27       Impact factor: 5.923

4.  Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes.

Authors:  Nathalie van Leeuwen-Kerkhoff; Kristina Lundberg; Theresia M Westers; Shahram Kordasti; Hetty J Bontkes; Malin Lindstedt; Tanja D de Gruijl; Arjan A van de Loosdrecht
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

Review 5.  The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes.

Authors:  Nora Chokr; Rima Patel; Kapil Wattamwar; Samer Chokr
Journal:  Adv Hematol       Date:  2018-11-01

6.  Abnormal Dendritic Cell-poiesis in Patients With Lower-risk Myelodysplastic Syndromes.

Authors:  Ángela Sánchez; Eduardo Anguita; Alberto Chaparro; Juan José Roldán-Etcheverry; Alberto López-García; Carlos Ramos-Acosta; Raluca Oancea; Diego Rodriguez-Muñoz; Susana Alemany
Journal:  Hemasphere       Date:  2020-01-22

7.  Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes.

Authors:  Nathalie Van Leeuwen-Kerkhoff; Theresia M Westers; Pino J Poddighe; Giovanni A M Povoleri; Jessica A Timms; Shahram Kordasti; Tanja D De Gruijl; Arjan A Van de Loosdrecht
Journal:  Haematologica       Date:  2022-03-01       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.